Technology Innovation Driving Pharma R&D Productivity and Efficiency

Over the last year, we have seen pharma innovation advance at an incredible pace to tackle the COVID-19 pandemic. As the need for improved productivity and efficiency in drug and biomedical R&D intensifies, pharmaceutical companies carefully choose their investment in technology innovation. Pharma R&D Week brings together thought leaders in biopharma R&D to discuss disruptive technologies and novel platforms, as well as strategies to cut costs and increase productivity. Building on the legacy of Cambridge Healthtech Institute’s 19th Annual World Preclinical Congress and 16th Annual Biomarker World Congress, Pharma R&D Week brings the latest technologies in translational biomarkers, liquid biopsy, immuno-oncology biomarkers, predictive preclinical models and 3-dimensional cell models, target discovery and validation, and phenotypic screening. Join us for special sessions on big pharma’s response to COVID-19, AI and digital health innovation, and precision medicine. The comprehensive 3-day program—packed with pharma and technology presentations, interactive panel discussions, and visionary keynotes—is designed to maximize collaboration and innovation. Our virtual platform provides seamless access to presentations and panel discussions, facilitated roundtables, virtual exhibit hall, one-on-one networking, and post-conference on-demand viewing… all without leaving your computer.